Citoxlab Group has acquired Xenometrics, a non-clinical contract research organization (CRO), as client requests continue to increase, says company president.
A year after implementing its policy on the publication of clinical data, reports on 50 medicines have been published and more than 80,000 documents downloaded – outcomes achieved through industry collaboration, says EMA.
Evidera has expanded its patient-centered research services, the advancement of which will enable the introduction of better treatments, faster, says team VP.
Vince & Associates Clinical Research is conducting a Phase Ib alcohol interaction study of Amygdala Neurosciences’ ANS-6637 for the potential treatment of substance abuse.
SynteractHCR has moved to a new 38,000 square foot facility in Carlsbad, CA as it looks to fill the mid-market CRO void created by recent consolidation, says CEO.
Niche, small-scale CROs can stand their own – despite a predicted increase in consolidation among small-sized contract services firms – says Clinical Trial Consultants (CTC) and data-focused Quanticate.
The People for the Ethical Treatment of Animals (PETA) is looking to send a researcher to learn about non-animal test methods – adoption of which it says is slowed by regulatory agency acceptance.
Pharma and diagnostic partners will gain access to a human cancer biospecimens and clinical data from patients to power clinical and translational research, says CRO.
The biometrics contract research organization (CRO) and clinical trial software provider is continuing with its expansions plans as it opens a new office in King of Prussia, Pennsylvania.
There are many opportunities in Asia Pacific for mid-sized CROs says PSI, after opening a new office in Seoul, South Korea in response to client requests.
Clintec International has opened a centre of excellence for clinical research and quality assurance capabilities as part of its headquarters expansion in Glasgow, Scotland.
The mid-size contract research organization (CRO) sector continues to evolve and surprise experts with rich valuations – and what seems to be a never ending list of transactions.
Eurofins Pharma Bioanalytical Services has launched a consulting program to support clients conducting large molecule preclinical and clinical studies.
Charles River Laboratories has acquired Brains On-Line in an ongoing effort to deepen its drug discovery capabilities and build out its portfolio through strategic acquisitions.
PRA Health Sciences has signed a definitive agreement to acquire Symphony Health Solutions Corporation for $530m as the industry increasingly looks to garner insight from real world data.
BioreclamationIVT has acquired the biospecimen and research services provider, Asterand Bioscience, following the purchase of TransCell Science earlier this year.
Certara has added externalization technology to its D360 scientific informatics platform to expedite collaboration between sponsors and their research partners.
Başkent University’s hospital cluster has joined Clinerion’s Patient Recruitment System (PRS) Platform, expanding sponsor access to potential clinical trial participants.
Integration of the Mapi Group has been initiated, Icon CEO Steve Cutler says, as the company looks to support customers facing increased pressure to demonstrate product value and safety.
BrainStorm Cell Therapeutics has contracted Worldwide Clinical Trials (WCT) to conduct its planned Phase III study of NurOwn in the treatment of amyotrophic lateral sclerosis (ALS).
Topstone Research has joined the Partner Program at Medrio, a Software as a Service (SaaS) company that provides electronic data capture (EDC) and eSource to clinical trials.
The international contract research organization (CRO) and non-profit organization have signed a three-year “teaming agreement” to advance clinical trials for gynecologic malignancies.
Patient-operated mobile technology will be demanded on all clinical trials, says mProve, as the industry undergoes an evolution and embraces digital health solutions.
The extended partnership provides CROS NT customers access to Medidata’s electronic data capture (EDC) solution as well as its randomization and trial supply management system (RTSM).
Evotec AG has received a payment of approximately €5m ($5.62m) as part of its strategic alliance with Bayer – which the company says is “well on track and very successful.”
PRA Health Sciences has launched a new Center for Pediatric Clinical Development and a correlating site network to facilitate patient recruitment and improved engagement and retention.
